Aging · 2021 · 10 citations · 17 references
MedicineOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis ResistanceApoptotic SignalingChemotherapy ResistanceColorectal CancerOncology Pharmacology5-Fluorouracil TreatmentApoptotic Signaling In CancerCancer Cell ApoptosisCaspase SignalingCell Death SensitizationChemotherapy SensitizationChemotherapy-induced ApoptosisSrc Family Activation
Currently, 5-Fluorouracil (5-FU) based chemotherapy is the primary option for colorectal cancer after surgery, whereas chemotherapy resistance related mortality is observed in a large proportion of patients. Anemoside B4 (AB4) is a triterpene saponin, which exhibits a considerable activity in oncotherapy. In this study, we explored the efficacy of AB4 in FU-based chemotherapy in colorectal cancer cells and the underlying molecular mechanisms. Our results indicated a significant synergistic activity of AB4 in 5-FU treated colorectal cancer cells. Furthermore, AB4 treatment eliminated colorectal cancer stem cells by promoting apoptotic cell death in 5-FU resistant colorectal cancer cells. Mechanically, AB4 activated caspase-9 pathway in 5-FU resistant colorectal cancer cells. Elevated Src activity induced cell apoptosis and cancer stem cells elimination effects in AB4 treated colorectal cancer cells. In conclusion, AB4 showed promising sensitization effect in the FU-based chemotherapy of colorectal cancer. Our study may pave a way to ameliorate FU-based chemotherapeutic efficiency in colorectal cancer.
17
Colorectal cancer statistics, 2014
Rebecca L. Siegel, Carol DeSantis, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2014 · 2.6K citations · Full text
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
Qiang Wang, Yanlong Shi, Kai Zhou et al. · Cell Death and Disease · 2018 · 152 citations · Full text